Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial, offering a more convenient and cheaper treatment option.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/annual-multiple-sclerosis-drug-effective-affordable-2025a1000r8s?src=rss
Author :
Publish date : 2025-10-09 11:39:00
Copyright for syndicated content belongs to the linked Source.
